California Allergy and Asthma Medical Group, Inc.
Quick facts
Marketed products
- Mometasone furoate 220
- Mometasone furoate 440 · Respiratory / Allergy / Immunology
Mometasone furoate is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator production.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- California Allergy and Asthma Medical Group, Inc. portfolio CI brief
- California Allergy and Asthma Medical Group, Inc. pipeline updates RSS
Frequently asked questions about California Allergy and Asthma Medical Group, Inc.
What are California Allergy and Asthma Medical Group, Inc.'s marketed drugs?
Top marketed products include Mometasone furoate 220, Mometasone furoate 440.
Related
- Mometasone furoate 220
- Mometasone furoate 440 · Respiratory / Allergy / Immunology
- Sector hub: All tracked pharma companies